Anti-inflammatory effects of resolvin-D1 on human corneal epithelial cells: In vitro study

Journal of Inflammation (United Kingdom)

Volumn 11, Issue 1, 2014, Pages

  Erdinest, Nir ^a   Ovadia, Haim ^a   Kormas, Ran ^a   Solomon, Abraham ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Anti inflammatory; Cornea; Corneal epithelium; Cytokines; Polyunsaturated fatty acids; Resolvin D1

Indexed keywords

ANTIINFLAMMATORY AGENT; DEXAMETHASONE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; OLEIC ACID; POLYINOSINIC POLYCYTIDYLIC ACID; RESOLVIN D1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA EPITHELIUM; DRUG MECHANISM; EPITHELIUM CELL; EYE INFLAMMATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOASSAY; IN VITRO STUDY; MULTIPLEX FLUORESCENT BEAD IMMUNOASSAY; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84895924186     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-11-6     Document Type: Article

References (47)

1. Role of immunity and inflammation in corneal and ocular surface disease associated with dry eye. Dana MR, Hamrah P, Adv Exp Med Biol 2002 506 Pt B 729 738
2. Contact lens wear alters the production of certain inflammatory mediators in tears. Thakur A, Willcox MD, Exp Eye Res 2000 70 3 255 259 10.1006/exer.1999.0767 10712811
3. Contact lenses and allergy. Lemp MA, Curr Opin Allergy Clin Immunol 2008 8 5 457 460 10.1097/ACI.0b013e32830e6adc 18769201
4. Docosahexaenoic acid, protectins and dry eye. Cortina MS, Bazan HE, Curr Opin Clin Nutr Metab Care 2011 14 2 132 137 10.1097/MCO.0b013e328342bb1a 21157308
5. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome. Marsh P, Pflugfelder SC, Ophthalmology 1999 106 4 811 816 10.1016/S0161-6420(99)90171-9 10201607
6. Corticosteroid-induced cataracts. Urban RC Jr, Cotlier E, Surv Ophthalmol 1986 31 2 102 110 10.1016/0039-6257(86)90077-9 3541262
7. Nonsteroidal anti-inflammatory drugs in ophthalmology. Kim SJ, Flach AJ, Jampol LM, Surv Ophthalmol 2010 55 2 108 133 10.1016/j.survophthal.2009.07.005 20159228
8. Topical cyclosporine A 0.05% in the treatment of keratoconjunctivitis sicca. Schrell C, Cursiefen C, Kruse F, Jacobi C, Klin Monbl Augenheilkd 2012 229 5 548 553 22189827
9. Nutritional supplements for dry eye syndrome. Rand AL, Asbell PA, Curr Opin Ophthalmol 2011 22 4 279 282 10.1097/ICU.0b013e3283477d23 21597374
10. Oral omega-6 essential fatty acid treatment in contact lens associated dry eye. Kokke KH, Morris JA, Lawrenson JG, Cont Lens Anterior Eye 2008 31 3 141 146 10.1016/j.clae.2007.12.001 18313350
11. Efficacy of a 2-month dietary supplementation with polyunsaturated fatty acids in dry eye induced by scopolamine in a rat model. Viau S, Maire MA, Pasquis B, Gregoire S, Acar N, Bron AM, Bretillon L, Creuzot-Garcher CP, Joffre C, Graefes Arch Clin Exp Ophthalmol 2009 247 8 1039 1050 10.1007/s00417-009- 1080-z 19415319
12. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR, Arch Ophthalmol 2008 126 2 219 225 10.1001/archophthalmol.2007.61 18268213
13. Anti-inflammatory effects of alpha linolenic Acid on human corneal epithelial cells. Erdinest N, Shmueli O, Grossman Y, Ovadia H, Solomon A, Invest Ophthalmol Vis Sci 2012 53 8 4396 4406 10.1167/iovs.12-9724 22669722
14. Resolution of inflammation: state of the art, definitions and terms. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O'Neill LA, Perretti M, Rossi AG, Wallace JL, FASEB J 2007 21 2 325 332 10.1096/fj.06-7227rev 17267386
15. Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids. Zhang MJ, Spite M, Annu Rev Nutr 2012 21 32 203 227
16. Resolvins and protectins in the termination program of acute inflammation. Ariel A, Serhan CN, Trends Immunol 2007 28 4 176 83 10.1016/j.it.2007.02.007 17337246
17. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac RL, J Exp Med 2002 196 8 1025 37 10.1084/jem.20020760 12391014
18. Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Serhan CN, Am J Pathol 2010 177 4 1576 91 10.2353/ajpath.2010. 100322 20813960
19. Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model. Li N, He J, Schwartz CE, Gjorstrup P, Bazan HE, J Ocul Pharmacol Ther 2010 26 5 431 9 10.1089/jop.2010.0019 20874497
20. Resolvin E1 (RX-10001) reduces corneal epithelial barrier disruption and protects against goblet cell loss in a murine model of dry eye. de Paiva CS, Schwartz CE, Gjorstrup P, Pflugfelder SC, Cornea 2012 31 11 1299 1303 10.1097/ICO.0b013e31823f789e 22257864
21. Regulation of MMP-9 production by human corneal epithelial cells. Li DQ, Lokeshwar BL, Solomon A, Monroy D, Ji Z, Pflugfelder SC, Exp Eye Res 2001 73 4 449 59 10.1006/exer.2001.1054 11825017
22. Beta-adrenergic and serotonergic responsiveness of rabbit corneal epithelial cells in culture. Jumblatt MM, Neufeld AH, Invest Ophthalmol Vis Sci 1983 24 8 1139 43 6135673
23. Partitioning of polyunsaturated fatty acids, which prevent cardiac arrhythmias, into phospholipid cell membranes. Pound EM, Kang JX, Leaf A, J Lipid Res 2001 42 3 346 51 11254745
24. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. De CR, Cybulsky MI, Clinton SK, Gimbrone MA Jr, Libby P, Arterioscler Thromb 1994 14 11 1829 36 10.1161/01.ATV.14.11.1829 7524649
25. Triggering of TLR3 by polyI:C in human corneal epithelial cells to induce inflammatory cytokines. Ueta M, Hamuro J, Kiyono H, Kinoshita S, Biochem Biophys Res Commun 2005 331 1 285 94 10.1016/j.bbrc.2005.02.196 15845391
26. Inhibition of inflammatory cytokine production in human corneal cells by dexamethasone, but not cyclosporin. Djalilian AR, Nagineni CN, Mahesh SP, Smith JA, Nussenblatt RB, Hooks JJ, Cornea 2006 25 6 709 14 10.1097/01.ico.0000208815. 02120.90 17077666
27. Dietary oleic acid as a control fatty acid for polyunsaturated fatty acid intervention studies: a transcriptomics and proteomics investigation using interleukin-10 gene-deficient mice. Knoch B, Barnett MP, Cooney J, McNabb WC, Barraclough D, Laing W, Roy NC, Biotechnol J 2010 5 11 1226 40 10.1002/biot.201000066 20872728
28. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C, J Immunol Methods 1995 184 1 39 51 10.1016/0022-1759(95)00072-I 7622868
29. Multiplexed particle-based flow cytometric assays. Vignali DA, J Immunol Methods 2000 243 1-2 243 55 10986418
30. A novel method for real time quantitative RT-PCR. Gibson UE, Heid CA, Williams PM, Genome Res 1996 6 10 995 1001 10.1101/gr.6.10.995 8908519
31. Dry eye syndrome. Javadi MA, Feizi S, J Ophthalmic Vis Res 2011 6 3 192 8 22454735
32. Topical ophthalmic cyclosporine: pharmacology and clinical uses. Donnenfeld E, Pflugfelder SC, Surv Ophthalmol 2009 54 3 321 38 10.1016/j.survophthal.2009.02.002 19422961
33. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, Yang R, Petasis NA, Serhan CN, J Exp Med 2005 201 5 713 22 10.1084/jem.20042031 15753205
34. Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Haworth O, Cernadas M, Yang R, Serhan CN, Levy BD, Nat Immunol 2008 9 8 873 9 10.1038/ni.1627 18568027
35. Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Aoki H, Hisada T, Ishizuka T, Utsugi M, Kawata T, Shimizu Y, Okajima F, Dobashi K, Mori M, Biochem Biophys Res Commun 2008 367 2 509 15 10.1016/j.bbrc.2008.01.012 18190790
36. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Arita M, Yoshida M, Hong S, Tjonahen E, Glickman JN, Petasis NA, Blumberg RS, Serhan CN, Proc Natl Acad Sci USA 2005 102 21 7671 6 10.1073/pnas.0409271102 15890784
37. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Jin Y, Arita M, Zhang Q, Saban DR, Chauhan SK, Chiang N, Serhan CN, Dana R, Invest Ophthalmol Vis Sci 2009 50 10 4743 52 10.1167/iovs.08-2462 19407006
38. Resolvin D1 protects mice from LPS-induced acute lung injury. Wang B, Gong X, Wan JY, Zhang L, Zhang Z, Li HZ, Min S, Pulm Pharmacol Ther 2011 24 4 434 41 10.1016/j.pupt.2011.04.001 21501693
39. Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. Hellmann J, Tang Y, Kosuri M, Bhatnagar A, Spite M, FASEB J 2011 25 7 2399 407 10.1096/fj.10-178657 21478260
40. Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. Bento AF, Claudino RF, Dutra RC, Marcon R, Calixto JB, J Immunol 2011 187 4 1957 69 10.4049/jimmunol.1101305 21724996
41. Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Xu ZZ, Zhang L, Liu T, Park JY, Berta T, Yang R, Serhan CN, Ji RR, Nat Med 2010 16 5 592 7 1p 10.1038/nm.2123 20383154
42. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, Yang R, Petasis NA, Serhan CN, Proc Natl Acad Sci USA 2010 107 4 1660 5 10.1073/pnas.0907342107 20080636
43. Resolvins E1 and D1 in choroid-retinal endothelial cells and leukocytes: biosynthesis and mechanisms of anti-inflammatory actions. Tian H, Lu Y, Sherwood AM, Hongqian D, Hong S, Invest Ophthalmol Vis Sci 2009 50 8 3613 20 10.1167/iovs.08-3146 19443724
44. Effects of omega-3 fatty acids on eye health. Hodge W, Barnes D, Schachter HM, Pan Y, Lowcock EC, Zhang L, Sampson M, Morrison A, Tran K, Miguelez M, Lewin G, Evid Rep Technol Assess (Summ) 2005 117 1 6 16111433
45. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG, Proc Natl Acad Sci USA 2004 101 22 8491 6 10.1073/pnas.0402531101 15152078
46. Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. Zhao Y, Joshi-Barve S, Barve S, Chen LH, J Am Coll Nutr 2004 23 1 71 8 10.1080/07315724.2004.10719345 14963056
47. Omega-3 fatty acids attenuate mucosal inflammation in premature rat pups. Ohtsuka Y, Okada K, Yamakawa Y, Ikuse T, Baba Y, Inage E, Fujii T, Izumi H, Oshida K, Nagata S, Yamashiro Y, Shimizu T, J Pediatr Surg 2011 46 3 489 95 10.1016/j.jpedsurg.2010.07.032 21376198